Results 141 to 150 of about 34,514 (185)

The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria. [PDF]

Nat Prod Bioprospect
Ghazaei C.
europepmc   +1 more source

CRISPR-Cas-Mediated Reprogramming Strategies to Overcome Antimicrobial Resistance. [PDF]

Pharmaceutics
Yoon B, Kim JA, Kang YK.
europepmc   +1 more source

CRISPR-based electrochemiluminescence biosensors: Principles, optimization strategies, and translational challenges - A review of recent progress. [PDF]

Food Chem (Oxf)
Yin X, Fan Z, Tong Z.
europepmc   +1 more source

CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research. [PDF]

Cells
Woronkowicz M, Thomas MN, Saram SJ, Carr AF, Alonso-Carriazo Fernandez A, Butt Z, Skopiński P, Ramsden CM.   +7 more
europepmc   +1 more source

Viral genome editing methods and applications in the CRISPR era. [PDF]

J Virol
Shin K, Kim ET.
europepmc   +1 more source

Editing <i>Candida</i>: Origins and Advances of CRISPR Tools. [PDF]

Biomolecules
Schulze A, Kainz K, Bauer MA, Carmona-Gutierrez D.   +3 more
europepmc   +1 more source

CRISPR-Cas9 trans-cleavage is hindered by a flanked R-loop, an elongated spacer, and an inactive HNH domain. [PDF]

Nat Commun
Montagud-Martínez R, Ruiz R, Baldanta S, Delicado-Mateo R, Rodrigo G.   +4 more
europepmc   +1 more source

Programmable molecular microscopy: CRISPR/Cas fluorescent probes revolutionizing spatiotemporal genomic imaging. [PDF]

Theranostics
Zhong XY, Yang YX, Xiong YF, Ye GC, Gong X, Zhong ML, He HD, Wang SG, Xia QD.   +8 more
europepmc   +1 more source

Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs. [PDF]

Saudi Pharm J
Almufarriji FM.
europepmc   +1 more source